FIG 2.
Performance and efficiency of cfDNA mNGS. (A) Potential pathogens detected by cfDNA mNGS. (B) Distribution of predominant pathogens in CSF samples. (C) Diagnostic efficiency by mNGS and conventional methods based on the clinical diagnosis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.